The disposition and effects of two doses of dichloroacetate in adults with severe falciparum malaria
Open Access
- 1 January 1996
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 41 (1) , 29-34
Abstract
1 Dichloroacetate (DCA) is a promising treatment for lactic acidosis complicating severe malaria. The pharmacokinetics, pharmacodynamics and toxicity of dichloroacetate were evaluated in 11 patients with severe malaria, and their lactate responses compared with nine control patients in an open–label prospective study. 2 Intravenous DCA (46 mg kg‐1 infused in 30 min) or saline placebo was given on admission to the study, and 12 h later, as an adjunct to standard quinine treatment. 3 An open one‐compartment model with the following parameters described the pharmacokinetics of DCA after one dose (mean [s.d.]): v = 0.44(0.2) 1 kg‐1; CL = 0.13[0.027] 1 h‐1 kg‐1; Cmax = 106[28] mg l‐1; t1/2, = 3.4(2.2)h. After two doses of DCA (n = 9) the pharmacokinetic parameters were similar to those after the first dose. 4 DCA decreased venous plasma lactate concentrations by 42% of baseline values 8 h after admission, normalized arterial pH from a mean(s.d.) of 7.367(0.063) to 7.39(0.1), and decreased the calculated base deficit from 9.2(7.3) mEq 1‐1 to 6. 4(10.4) mEq 1‐1. In control patients lactate concentrations fell by ˜14% of baseline concentrations (P <0.02 compared with DCA recipients). Venous lactate concentrations fell a further 16% from baseline values after the second dose of DCA but this change was not significantly different from controls. There was no electrocardiographic or other evidence of toxicity associated with DCA. 5 These data suggest that a single intravenous infusion of DCA rapidly reduces hyperlactataemia in patients severely ill with malaria, and that DCA should be evaluated further as an adjunct to conventional antimalarial and supportive measures for such patients with lactic acidosis.Keywords
This publication has 16 references indexed in Scilit:
- Plasmodium berghei Infection: Dichloroacetate Improves Survival in Rats with Lactic AcidosisExperimental Parasitology, 1995
- Dichloroacetate for lactic acidosis in severe malaria: A pharmacokinetic and pharmacodynamic assessmentMetabolism, 1994
- Glycerol metabolism in severe falciparum malariaMetabolism, 1994
- Quinine in severe falciparum malaria: evidence of declining efficacy in ThailandTransactions of the Royal Society of Tropical Medicine and Hygiene, 1994
- Plasmodium falciparum: In Vitro Studies of the Pharmacodynamic Properties of Drugs Used for the Treatment of Severe MalariaExperimental Parasitology, 1993
- The Pathophysiology of Malaria1992
- Plasmodium berghei: Lactic acidosis and hypoglycaemia in a rodent model of severe malaria; effects of glucose, quinine, and dichloroacetateExperimental Parasitology, 1991
- Treatment of malaria: some considerations and limitations of the current methods of assessmentTransactions of the Royal Society of Tropical Medicine and Hygiene, 1989
- HYPOGLYCAEMIA IN AFRICAN CHILDREN WITH SEVERE MALARIAThe Lancet, 1987
- Severe Hypoglycemia and Hyperinsulinemia in Falciparum MalariaNew England Journal of Medicine, 1983